Literature DB >> 3125517

Resistance to quinolones.

R P Mouton1.   

Abstract

Resistance to quinolones is only due to mutations. The mechanism and the range of quinolones involved, depend on the locus of the chromosomal mutation e.g. a mutation in the gyr A locus is associated with resistance due to changes in the gyrase. Using high inocula in vitro, varying, but relatively low mutation rates of resistance to fluoroquinolones have been found (10(-6)-10(-12). In vitro transfers of bacterial strains in increasing concentrations of quinolones yield parallel increases of the MIC's of most quinolones; however, the MIC's of the most active quinolones like ciprofloxacin usually remain below concentrations achievable in vivo. Exceptions are MIC's for Pseudomonas aeruginosa and staphylococci. Combined resistance to quinolones and other antibiotics was observed after in vitro transfers as well as in mutants (10(-6)-10(-8) isolated from a high inoculum. Changes in the outer membrane proteins have been found in these mutants. Clinical resistance to fluoroquinolones is rare except in Pseudomonas aeruginosa and staphylococci.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3125517     DOI: 10.1007/bf02075252

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  15 in total

Review 1.  Recalibrated linkage map of Escherichia coli K-12.

Authors:  B J Bachmann; K B Low; A L Taylor
Journal:  Bacteriol Rev       Date:  1976-03

2.  Cross-resistance of nalidixic acid resistant Enterobacteriaceae to new quinolones and other antimicrobials.

Authors:  L J Piddock; J M Diver; R Wise
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

3.  Resistance to ciprofloxacin.

Authors:  S T Chapman; D C Speller; D S Reeves
Journal:  Lancet       Date:  1985-07-06       Impact factor: 79.321

4.  Frequency of appearance of resistant variants to norfloxacin and nalidixic acid.

Authors:  G J Duckworth; J D Williams
Journal:  J Antimicrob Chemother       Date:  1984-05       Impact factor: 5.790

5.  A critical evaluation of nalidixic acid in urinary-tract infections.

Authors:  A R Ronald; M Turck; R G Petersdorf
Journal:  N Engl J Med       Date:  1966-11-17       Impact factor: 91.245

6.  Combined resistance to quinolones and beta-lactams after in vitro transfer on single drugs.

Authors:  R P Mouton; S L Mulders
Journal:  Chemotherapy       Date:  1987       Impact factor: 2.544

7.  Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.

Authors:  K Hirai; H Aoyama; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

Review 8.  The mode of action of 4-quinolones and possible mechanisms of resistance.

Authors:  J T Smith
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

9.  Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

Authors:  C C Sanders; W E Sanders; R V Goering; V Werner
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

10.  Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.

Authors:  W Cullmann; M Stieglitz; B Baars; W Opferkuch
Journal:  Chemotherapy       Date:  1985       Impact factor: 2.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.